Causal inference study of plasma proteins and blood metabolites mediating the effect of obesity-related indicators on osteoporosis

TL;DR

This study explores how obesity might protect against osteoporosis, possibly through specific proteins and metabolites like EHMT2 and alanine.

Contribution

The study identifies plasma proteins and blood metabolites that may mediate the protective effect of obesity on osteoporosis using causal inference methods.

Findings

31 obesity-related indicators show a significant causal relationship with osteoporosis.

25 plasma proteins and 7 blood metabolites are linked to osteoporosis risk.

EHMT2 in plasma proteins and alanine in blood metabolites may mediate the protective effect of obesity on osteoporosis.

Abstract

Osteoporosis and obesity are both major global public health problems. Observational studies have found that osteoporosis might be related to obesity. Mendelian randomization (MR) analysis could overcome the limitations of observational studies in assessing causal relationships.

This study aims to evaluate the causal potential relationship between obesity-related indicators and osteoporosis by using a two-sample MR analysis and to identify potential mediators.

A total of 53 obesity-related indicators, 3,282 plasma protein lists, and 452 blood metabolite lists were downloaded from the public data set as instrumental variables, and the osteoporosis GWAS data of the MRC IEU Open GWAS database was used as the outcome indicators. Using two-sample univariate MR, multivariate MR, and intermediate MR, the causal relationship and mediating factors between obesity-related indicators and osteoporosis were identified.

The IVW model results show that 31 obesity-related indicators may have a significant causal relationship with osteoporosis (P < 0.05), except for waist circumference (id: Ieu-a-71, OR = 1.00566); the remaining 30 indicators could reduce the risk of osteoporosis (OR: 0.983–0.996). A total of 25 plasma protein indicators may have a significant causal relationship with osteoporosis (P < 0.05), and 10 of them, such as ANKED46, KLRF1, and LPO, CA9 may have a protective effect on osteoporosis (OR: 0.996–0.999), while the other 15 such as ATP1B1, zinc finger protein 175, could increase the risk of osteoporosis (OR: 1.001–1.004). For blood metabolite indicators, except for alanine (id: Met a-469, OR: 1.071), the other six blood metabolite indicators including uridine and 1-linoleoylglycerophosphoethanolaminecan may have a protective effect on osteoporosis (P < 0.05, OR: 0.961–0.992). The direction of causal relationship of MR is all correct; the heterogeneity is all not significant and not affected by horizontal pleiotropy. Using multivariate and mediated MR analysis, it was found that the protective effect of obesity-related indicators against osteoporosis may be mediated by histone-lysine N-methyltransferase in plasma proteins and alanine in blood metabolites.

Obesity may confer a protective effect against osteoporosis, potentially mediated by EHMT2 in plasma proteins and alanine in blood metabolites. Further empirical research is required to fully elucidate the mechanisms behind the influence of obesity on osteoporosis. Interventions on obesity-related factors to reduce the risk of osteoporosis while controlling other adverse effects associated with obesity may require further research.

Figures